-
Signature
-
/s/ Stephen Vander Stoep, attorney-in-fact for Pamela J. Cramer
-
Issuer symbol
-
RYTM
-
Transactions as of
-
20 Nov 2025
-
Transactions value $
-
-$260,128
-
Form type
-
4
-
Filing time
-
24 Nov 2025, 16:15:18 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Cramer Pamela J. |
Chief Human Resources Officer |
C/O RHYTHM PHARMACEUTICALS, INC., 222 BERKELEY STREET, 12TH FLOOR, BOSTON |
/s/ Stephen Vander Stoep, attorney-in-fact for Pamela J. Cramer |
24 Nov 2025 |
0001873517 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RYTM |
Common Stock |
Options Exercise |
$91.6K |
+3.35K |
+16.09% |
$27.35 |
24.2K |
20 Nov 2025 |
Direct |
|
| transaction |
RYTM |
Common Stock |
Sale |
-$352K |
-3.35K |
-13.86% |
$105.00 |
20.8K |
20 Nov 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RYTM |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-3.35K |
-22.22% |
$0.00 |
11.7K |
20 Nov 2025 |
Common Stock |
3.35K |
$27.35 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: